top of page

Mwandishi

Mhariri:

Imeboreshwa:

< Orodha kuu

ULY CLINIC

ULY CLINIC

Jumanne, 14 Julai 2026, 12:55:47 UTC

Strongyloidiasis Management

Strongyloidiasis management


Definition

Strongyloidiasis is a small intestinal infestation caused by Strongyloides stercoralis. It is usually asymptomatic in immunocompetent adults but can cause life-threatening hyperinfection and disseminated strongyloidiasis in immunocompromised individuals, with high mortality rates.


Clinical presentation

  • Pruritic papulo-vesicular rash at the site of larval penetration

  • Urticarial rash involving the perineal region and extending to the buttocks, thighs, and abdomen

  • Chronic cough

  • Colicky abdominal pain

  • Chronic diarrhoea

  • Passage of mucus in stool

  • Weight loss

  • Hyperinfection syndrome


Investigations

  • Stool examination:

    • Evidence of rhabditiform larvae on wet mount microscopy

  • Serology:

    • ELISA demonstrating anti-Strongyloides antibodies


Pharmacological treatment

Albendazole

  • Dose: 400 mg

  • Route: Oral (PO)

  • Frequency: Every 12 hours

  • Duration: 3 days


Follow-up

  • Repeat treatment after 4 weeks if stool findings remain positive.

OR

Ivermectin

  • Dose: 200 micrograms/kg

  • Route: Oral (PO)

  • Frequency: Every 24 hours

  • Duration: 2 days


Management of disseminated or hyperinfection syndrome

  • Continue treatment for 10 days in cases of disseminated strongyloidiasis or hyperinfection syndrome.


Possible complications

  • Hyperinfection syndrome

  • Disseminated strongyloidiasis

  • Severe gastrointestinal disease

  • Severe pulmonary involvement

  • High mortality in immunocompromised patients

Imeandikwa:

Jumatatu, 1 Juni 2026, 15:40:09 UTC

References:

bottom of page